Introduction: Literature about trichoscopy of permanent chemotherapy-induced alopecia (pCIA) is still scarce, while no data were published regarding reflectance confocal microscopy (RCM). The aim of our study is to monitor the different phases of chemotherapy-induced alopecia development with trichoscopy and RCM, in order to identify predictor factors for permanent alopecia.

Methods: This multicentre, prospective, observational study evaluated patients with cancer who were candidates for chemotherapy with a drug implicated in pCIA development. Patients were followed for the next 2 years after recruitment.

Results: A total of 77 patients were enrolled. Six months after the discontinuation of chemotherapy in all patients with pCIA, trichoscopic examination revealed a diffuse presence of multiple yellow dots, the persistence of regrowing hairs, and an increase degree of miniaturization in comparison to baseline. RCM detected the permanence of inflammatory cells over time, especially around the adnexal structures, which led to the appearance of fibrosis and alteration of the normal rimming.

Conclusions: Trichoscopy and RCM allowed one to detect the different phases of chemotherapy-induced alopecia development. The following predictor factors for pCIA were identified: a positive history of cyclophosphamide- and taxane-based chemotherapy; a diffuse presence of multiple yellow dots at trichoscopy; onset and persistence of a diffuse inflammatory infiltrate at RCM.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13555-025-01378-2DOI Listing

Publication Analysis

Top Keywords

chemotherapy-induced alopecia
16
factors permanent
8
permanent chemotherapy-induced
8
reflectance confocal
8
confocal microscopy
8
phases chemotherapy-induced
8
alopecia development
8
trichoscopy rcm
8
predictor factors
8
diffuse presence
8

Similar Publications

Introduction: Literature about trichoscopy of permanent chemotherapy-induced alopecia (pCIA) is still scarce, while no data were published regarding reflectance confocal microscopy (RCM). The aim of our study is to monitor the different phases of chemotherapy-induced alopecia development with trichoscopy and RCM, in order to identify predictor factors for permanent alopecia.

Methods: This multicentre, prospective, observational study evaluated patients with cancer who were candidates for chemotherapy with a drug implicated in pCIA development.

View Article and Find Full Text PDF

Purpose: To investigate the effects of chemotherapy-induced alopecia (CIA) on the distress and quality of life of male patients with cancer and to identify characteristics that place these patients at risk for higher distress and lower quality of life.

Participants & Setting: 146 patients with alopecia seen in an outpatient chemotherapy unit and receiving at least one cycle of chemotherapy participated in the study from March to December 2023.

Methodologic Approach: Data were collected via face-to-face interviews using an individual information form, the National Comprehensive Cancer Network Distress Thermometer, and the CIA Quality-of-Life Scale.

View Article and Find Full Text PDF

Permanent chemotherapy-induced alopecia (PCIA), defined as the persistence of hair loss for > 6 months following chemotherapy cessation, is a rare pediatric diagnosis. A retrospective chart review was conducted to characterize cases of PCIA not previously reported in pediatric Ewing's sarcoma (ES) patients after completion of therapeutic chemotherapy, comparing demographic factors, cumulative chemotherapy dosing, family history of hair loss, and treatment methodologies with a control group. Of 12 patients with an history of pediatric ES, three were diagnosed with PCIA.

View Article and Find Full Text PDF

reast cancer is the most common malignancy among women in the United States (American Cancer Society in Key Statistics for Breast Cancer. American Cancer Society, Atlanta, GA). Hair loss is common among women undergoing breast cancer treatment, however limited research has systematically characterized treatment-specific patterns of hair loss.

View Article and Find Full Text PDF

S100A8 induces cyclophosphamide-induced alopecia via NCF2/NOX2-mediated ferroptosis.

Free Radic Biol Med

March 2025

Department of Dermatology, Hangzhou Third People's Hospital, Affiliated Hangzhou Dermatology Hospital, Zhejiang University School of Medicine, Hangzhou, 310009, China. Electronic address:

Chemotherapy-induced alopecia (CIA), commonly associated with agents such as cyclophosphamide (CYP), is a prevalent and distressing side effect of numerous chemotherapeutic treatments, significantly impacting patients' quality of life. S100A8, a calcium-binding protein involved in inflammatory responses and oxidative stress regulation, plays a pivotal role in cellular homeostasis. In this study, we investigated the involvement of S100A8 in ferroptosis within a CYP-induced CIA mouse model.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!